Thiamine as a Metabolic Resuscitator in Septic Shock
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The major goal of this project is to determine whether the use of thiamine in patients with
septic shock will result in attenuation of lactic acidosis and a more rapid reversal of
shock.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Beth Israel Deaconess Medical Center
Collaborators:
National Center for Complementary and Integrative Health (NCCIH) National Institutes of Health (NIH)